Mimedx (MDXG) Operating Margin Growth (3y) (2014 - 2026)
Mimedx (MDXG) Operating Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mimedx | 635.35 Mn | 475.58 Mn | 41.62 Mn | -2,673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,673.00 |
| Dec 31, 2025 | 264.00 |
| Sep 30, 2025 | 3,001.00 |
| Jun 30, 2025 | 2,695.00 |
| Mar 31, 2025 | 2,515.00 |
| Dec 31, 2024 | 937.00 |
| Sep 30, 2024 | 1,498.00 |
| Jun 30, 2024 | 2,749.00 |
| Mar 31, 2024 | 2,701.00 |
| Dec 31, 2023 | 4,131.00 |
| Sep 30, 2023 | 2,871.00 |
| Jun 30, 2023 | 2,425.00 |
| Mar 31, 2023 | 2,179.00 |
| Dec 31, 2022 | 2,159.00 |
| Sep 30, 2022 | -2,647.00 |
| Jun 30, 2022 | 1,091.00 |
| Mar 31, 2022 | 436.00 |
| Dec 31, 2021 | 1,219.00 |
| Sep 30, 2021 | -213.00 |
| Jun 30, 2021 | -236.00 |